Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

283.30B

Market cap283.30B

Price-Earnings ratio

18.64

Price-Earnings ratio18.64

Dividend yield

1.93%

Dividend yield1.93%

Average volume

11.60M

Average volume11.60M

High today

$62.75

High today$62.75

Low today

$61.22

Low today$61.22

Open price

$62.45

Open price$62.45

Volume

7.89M

Volume7.89M

52 Week high

$148.15

52 Week high$148.15

52 Week low

$57.00

52 Week low$57.00

NVO News

TipRanks 2h

Novo Nordisk downgraded to Sell from Buy at DBS Bank

DBS Bank downgraded Novo Nordisk (NVO) to Sell from Buy with a DKK 330 price target Published first on TheFly – the ultimate source for real-time, market-movin...

TipRanks 14h

Novo Nordisk downgraded to Market Perform from Outperform at BMO Capital

BMO Capital downgraded Novo Nordisk (NVO) to Market Perform from Outperform with a $64 price target Published first on TheFly – the ultimate source for real-ti...

Sherwood News 3d

Novo Nordisk slumps following trial results for Eli Lilly's weight-loss pill

Novo Nordisk , the Danish maker of Ozempic and Wegovy, fell almost 10% early on Tuesday — its first trading session since rival Eli Lilly unveiled strong trial...

Analyst ratings

62%

of 34 ratings

Buy

61.8%

Hold

29.4%

Sell

8.8%

More NVO News

TipRanks 6d

Novo Nordisk Faces Stock Dip Amidst Market Challenges

Novo Nordisk ( (NVO) ) has fallen by -12.08%. Read on to learn why. Novo Nordisk has experienced a notable decline in its stock price, dropping by 12.08% over...